NCT03089918View on ClinicalTrials.gov

A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand 11C-JNJ-63779586 in the Human Brain

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

May 17, 2017

Primary Completion Date

August 24, 2018

Study Completion Date

August 24, 2018

Conditions
Alzheimer Disease
Interventions
DRUG

11C-JNJ-63779586

Participants will receive IV injection with 11C-JNJ-63779586 in Part A and Part B.

Trial Locations (2)

2610

University of Antwerpen, Wilrijk

3000

UZ Leuven, Leuven

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT03089918 - A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand 11C-JNJ-63779586 in the Human Brain | Biotech Hunter | Biotech Hunter